Trombolik cardio tablets 100 mg. №20


Manufacturer: Ukraine



To reduce the risk of: death in patients with suspected acute myocardial infarction; incidence and death in patients after myocardial infarction; transient ischemic attacks (TIA) and stroke in patients with TIA; morbidity and death with stable and unstable angina; myocardial infarction in patients with a high risk of developing cardiovascular complications (diabetes mellitus, controlled arterial hypertension) and people with a multi-factor risk of cardiovascular diseases (hyperlipidemia, obesity, smoking, old age). For prevention: thrombosis and embolism after vascular surgery (percutaneous transluminal catheter angioplasty (PTCA), carotid endarterectomy, coronary artery bypass grafting (CABG), arteriovenous bypass grafting); deep vein thrombosis and pulmonary embolism after prolonged immobilization (after surgery); For secondary prevention of stroke.